| scholarly article | Q13442814 |
| editorial | Q871232 |
| P50 | author | Ruth Tachezy | Q39066606 |
| P2093 | author name string | Lukas Rob | |
| Helena Robova | |||
| P2860 | cites work | Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis | Q24647649 |
| Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
| Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study | Q30307042 | ||
| Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction | Q34955292 | ||
| Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice | Q35738881 | ||
| HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications | Q35835143 | ||
| Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland | Q36433491 | ||
| Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study | Q36451743 | ||
| Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe | Q38023288 | ||
| Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials | Q38160099 | ||
| Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer | Q43596600 | ||
| Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance | Q45008006 | ||
| Cervical cancer screening policies and coverage in Europe | Q45177500 | ||
| Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication | Q47860026 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1137-1140 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Future Oncology | Q2781597 |
| P1476 | title | Cervical cancer: what is the optimal age for routine testing? | |
| P478 | volume | 11 |
Search more.